SATSUMA PHARMACEUTICALS, INC. (STSA) Social Stream



SATSUMA PHARMACEUTICALS, INC. (STSA): $2.72

0.13 (+5.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add STSA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Satsuma Pharmaceuticals Inc (STSA) Price Targets From Analysts

Use the tables below to see what analysts covering Satsuma Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-22 3 $15 $5 $11.666 $3.82 205.39%

The Trend in the Analyst Price Target


STSA's average price target has moved down $0 over the prior 33 weeks.

STSA reports an average of 106.51% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 3 15 3.5 7.25 5.96 21.64%
2021-04-17 5 15 4.0 8.13 5.07 60.36%
2021-05-08 4 15 4.0 8.67 5.09 70.33%
2021-06-13 4 15 5.0 9.00 5.14 75.1%
2021-07-17 4 15 5.0 11.67 5.87 98.81%

STSA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


STSA's average broker recommendation rating improved by 1.08 over the prior 43 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Satsuma Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is higher than 11.04% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, Satsuma Pharmaceuticals Inc's number of analysts covering the stock is higher than 12.6% of them.
  • In terms of how Satsuma Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than 13.01% of that group.
  • In terms of how Satsuma Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 71.27% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Satsuma Pharmaceuticals Inc are SRRA, SPRO, and SPRB.

Is STSA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 41.3256 seconds.